- FoI Number
- 2024-814
- Subject
- Oncology
- Date Received
- 27/03/2025
- Request and Response
-
- Please confirm the number of patients treated for cancer by patient type for the calendar year (2024).
Number of Oncology patients (Calendar year 2024)
Patients
Total
38 + ( haematology 10)
NHS Funded
38 + (haematology 10)
Privately Funded
0
- Patients treated with immuno-oncology products
Please provide the total number of patients who have been treated with an Immuno-oncology product latest calendar year (2024) by patient type.
Number of Oncology patients treated with an Immuno-oncology product (Calendar year 2024)
Patients
Total
8
NHS Funded
8
Privately Funded
0
- Prescribing of specific Immuno-oncology products.
For the latest calendar year (2024), please provide the number of patients treated with the following Immuno-oncology products:
Number of Oncology patients treated with the following Immuno-oncology product (Calendar year 2024)
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Nivolumab / Relatlimab (Opdualag)
Total
5
<5
0
NHS Funded
5
<5
0
Privately funded
0
0
0
Where we have given <5 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
